What are CDKs and why are they important for cell division?

Cyclin-dependent kinases (CDKs) are regulatory proteins that control progression through the cell cycle by phosphorylating target proteins. CDKs work with cyclins to drive cells through different phases, making them essential for coordinating DNA replication and cell division. Their activity must be tightly regulated to prevent uncontrolled proliferation.

How do CDK inhibitors work to stop cell proliferation?

CDK inhibitors block the enzymatic activity of cyclin-dependent kinases, preventing them from phosphorylating downstream target proteins. This halts cell cycle progression by preventing cells from advancing through critical checkpoints. By inhibiting CDK activity, cells cannot proceed with DNA replication or mitosis.

What is the relationship between CDK inhibition and cancer treatment?

CDK inhibitors are used therapeutically to stop uncontrolled cancer cell division by preventing CDK-cyclin complexes from driving proliferation. Cancer cells often have dysregulated CDK activity, making them dependent on continuous cell cycle progression. Inhibiting CDKs forces cancer cells to exit the cycle or undergo apoptosis.

Which cyclins partner with CDKs at different cell cycle stages?

Different cyclin-CDK complexes regulate specific phases: cyclin E-CDK2 controls G1/S transition, cyclin A-CDK2 drives S phase, and cyclin B-CDK1 regulates G2/M transition. Each complex activates phase-specific proteins required for DNA replication and chromosome segregation. Cyclin levels fluctuate throughout the cell cycle to ensure proper timing.

What happens to cells when CDK activity is completely blocked?

When CDK activity is inhibited, cells cannot phosphorylate proteins needed for cell cycle progression and become arrested at specific checkpoints. Prolonged CDK inhibition triggers cell death pathways, including apoptosis, preventing damaged or abnormal cells from dividing. This mechanism is exploited in cancer therapy to eliminate rapidly dividing cells.

How do checkpoint mechanisms use CDK inhibition to maintain genomic stability?

Cell cycle checkpoints monitor DNA integrity and activate CDK inhibitors when damage is detected, halting progression until repairs are complete. This protective mechanism prevents replication of damaged DNA and transmission of mutations to daughter cells. CDK inhibition at checkpoints is essential for maintaining genomic stability and preventing cancer development.

34.5

Inhibition of CDK Activity

4.5K views02:34 min

During cell cycle transitions, Cdk activity is regulated by multiple proteins, ensuring controlled cell growth, complete DNA replication, and mitotic distribution of the chromosomes to daughter cells.

In the absence of regulatory proteins, an abnormal cell goes unchecked, leading to conditions such as cancer.

In a normal cell, Cdk activity is regulated through multiple mechanisms including cyclin degradation, inhibitory phosphorylation, and inhibitory conformational changes induced by Cdk inhibitor binding.

Cyclin levels are known to fluctuate during the cell cycle. Cdks are only active when bound to cyclin, therefore, cyclin degradation leaves Cdks inactive and unable to promote the transition to the next cell cycle stage.

In another mechanism, a kinase named Wee1, phosphorylates the active site in Cdk. This phosphorylation inhibits the activity of the cyclin-Cdk complex.

Additionally, Cdk inhibitors or CKIs, such as p16, p21, and p27, regulate Cdk activity through inhibitory conformational changes.

For instance, if DNA damage occurs during G1, p16 interacts with the cyclin-Cdk complex. This interaction causes a large structural rearrangement, detaching the bound cyclin, causing Cdk inactivation.

DNA damage in the G1 phase can also trigger the tumor suppressor protein, p53, to activate p21.

G1/S-Cdk and S-Cdk complexes are bound and inhibited by p21, arresting the cells in the G1 phase, and allowing enough time for DNA repair.

For the G1/S phase transition to take place, the cell is required to have all the resources needed for DNA replication. If the cell lacks the necessary resources, p27 binds to G1/S-Cdk and S-Cdk complexes, inhibiting the enzyme activity.

Once favorable conditions for cell cycle progression are met, p27 is degraded, restoring Cdk activity and promoting cell transition.

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be r…

Browse More Videos

CDK Activity

CDK Inhibition

Cell Cycle Regulation

Cyclin dependent Kinase

Cell Division

Cancer Therapy

Signal Transduction

Explore Related Chapters

Chapter 1

Inhibition of CDK Activity

Browse More Videos

Cells, Genomes, and Evolution

Biochemistry of the Cell

Energy and Catalysis

Introduction to Metabolism

Protein Structure

Protein Function

Structure and Organization of DNA

DNA Replication and Repair

Transcription: DNA to RNA

Translation: RNA to Protein

Control of Gene Expression

Membrane Structure and Components

Membrane Transport and Active Transporters

Channels and the Electrical Properties of Membranes

Transmembrane Transport in Endoplasmic Reticulum and Peroxisomes

Intracellular Compartments and Protein Sorting

Intracellular Membrane Traffic

Endocytosis and Exocytosis

Mitochondria and Energy Production

Chloroplasts and Photosynthesis

Principles of Cell Signaling

Signaling Networks of G Protein-coupled Receptors

Signaling Networks of Kinase Receptors

Alternative Signaling Routes in Gene Expression

The Cytoskeleton I: Actin and Microfilaments

The Cytoskeleton II: Microtubules and Intermediate Filaments

Extracellular Matrix in Animals

Cell-Matrix Interactions

Cell-Cell Interactions

Cell Polarization and Migration

Plant Cell Structure and Organization

Analyzing Cells and Proteins

Visualizing Cells, Tissues, and Molecules

Cell Division

Meiosis

Cell Death

Cancer

Stem Cell Biology And Renewal in Epithelial Tissue

A Hierarchical Stem-Cell System: Blood Cell Formation

Fibroblast Transformation and Muscle Stem Cells

Regeneration and Repair

Embryonic and Induced Pluripotent Stem Cells

34.5 : Inhibition of CDK Activity

34.1 : What is the Cell Cycle?

34.2 : Interphase

34.3 : The Cell Cycle Control System

34.4 : Positive Regulator Molecules

34.6 : S-Cdk Initiates DNA Replication

34.7 : M-Cdk Drives Transition Into Mitosis

34.8 : Mitogens and the Cell Cycle

34.9 : Replicative Cell Senescence

34.10 : Abnormal Proliferation

34.11 : Cells Coordinate Growth and Proliferation